AGIOS PHARMACEUTICALS, INC. AGIO Balance Sheet

Agios pharmaceuticals, inc. (AGIO)

Balance Sheet / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Dec'12
Assets
Current assets:
Cash and cash equivalents
89,093	80,931	81,709	83,580	103,443	70,502	156,478	210,323	364,469	102,724	132,741	138,717	200,278	160,754	285,502	234,048	39,035	71,764	80,048	72,533	35,256	14,031	70,049	108,247	32,837	71,560	106,011	77,481	91,297
Marketable securities
439,528	483,946	370,188	411,810	421,114	514,800	513,414	506,582	417,981	321,212	375,187	447,325	279,480	380,560	293,595	231,321	273,859	245,238	272,317	297,261	309,450	328,034	149,921	130,233	129,432	95,209	88,945	21,794	36,679
Accounts receivable, net
11,813	8,952	7,106	7,147	4,355	5,076	2,631	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Collaboration receivable – related party
2,577	1,539	1,838	2,524	2,319	2,462	3,395	19,326	3,512	2,448	3,489	4,842	11,265	4,886	8,182	7,853	6,814	8,225	9,078	10,474	7,017	6,492	18,759	-	-	476	-	-	-
Collaboration receivable – other
2,033	1,928	869	2,222	1,640	670	440	440	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Royalty receivable – related party
3,300	2,900	2,600	2,700	2,200	2,234	1,863	1,573	1,417	1,222	715	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Inventory
9,778	7,331	5,849	4,659	2,328	869	863	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Tenant improvement and other receivables
-	-	-	-	-	-	-	-	-	-	859	779	3,452	3,428	3,387	2,014	571	3,374	2,992	5,282	6,906	2,334	-	-	-	-	-	-	-
Unbilled collaboration receivable - related party
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,619	-	-	-	-
Prepaid expenses and other current assets
29,152	24,177	19,985	19,063	19,696	17,167	16,458	15,538	15,614	17,655	15,316	13,018	12,391	10,264	10,277	8,923	9,190	8,728	7,225	4,602	5,512	4,814	4,990	2,842	3,033	2,502	2,616	2,011	922
Refundable income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,841	3,841	3,841	4,496	-	-	-	-
Deferred tax assets, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,246	1,247	1,246
Total current assets
587,274	611,704	490,144	533,705	557,095	613,780	695,542	753,782	802,993	445,261	528,307	604,681	506,866	559,892	600,943	484,159	329,469	337,329	371,660	390,152	364,141	359,546	247,560	245,163	172,417	169,747	198,818	102,533	130,144
Marketable securities
84,503	152,929	88,579	128,649	183,234	220,119	208,508	219,724	212,297	143,814	133,804	129,899	23,423	32,250	43,499	46,926	42,860	58,905	55,621	64,243	95,258	125,382	17,917	22,631	5,005	27,125	13,412	-	-
Operating lease assets
91,440	93,643	95,833	98,500	57,768	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Property and equipment, net
33,840	31,472	24,060	23,016	23,974	24,320	24,613	24,134	23,732	24,431	24,019	24,771	24,139	25,337	26,261	25,134	22,950	23,220	21,127	19,328	14,297	6,386	3,677	3,210	3,452	3,758	3,551	3,818	3,565
Financing lease assets
881	993	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	571	571	571	571	571	571
Deferred tax assets, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,706	2,706	2,706
Other assets
1,800	0	0	0	60	238	416	595	1,104	891	1,070	1,249	2,888	1,615	1,339	1,382	838	611	678	660	640	590	454	455	467	4	11	1,624	22
Total assets
799,738	890,741	698,616	783,870	822,131	858,457	929,079	998,235	1,040,126	614,397	687,200	760,600	557,316	619,094	672,042	557,601	396,117	420,065	449,086	474,383	474,336	491,904	269,608	272,030	181,912	201,205	219,069	111,252	137,008
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable
18,707	21,896	21,511	15,435	12,413	17,880	16,616	17,320	17,932	22,767	17,899	23,409	16,152	17,106	15,424	18,448	13,746	14,748	8,971	8,914	12,640	11,067	6,225	5,388	4,411	3,678	2,140	3,038	3,308
Accrued expenses
39,631	53,142	46,750	49,218	37,199	42,147	25,303	25,793	17,005	34,031	30,760	29,641	25,114	32,002	22,808	14,414	12,247	15,996	15,985	11,584	15,604	14,020	10,004	5,456	3,841	6,586	4,764	3,586	1,708
Deferred revenue – related party
4,748	10,933	16,873	18,454	22,167	32,710	42,141	41,132	39,212	37,842	35,867	37,069	37,690	35,913	36,415	31,469	16,523	19,665	22,650	22,608	6,886	35,686	18,847	33,644	25,072	25,072	25,072	25,072	25,072
Operating lease liabilities
6,466	6,642	7,298	6,397	9,128	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income taxes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,462	5,257	5,141	4,875
Financing lease liabilities
306	273	0	0	0	766	686	625	550	301	3,586	3,529	3,473	3,412	3,356	2,933	2,539	2,479	2,150	2,092	1,245	310	-	142	133	123	-	104	85
Other current liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4	6	8	8	624	9	144	-	-
Restricted stock liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	38	65
Total current liabilities
69,858	92,886	92,432	89,504	80,907	93,503	84,746	84,870	74,699	94,941	88,112	93,648	82,429	88,433	78,003	67,264	45,055	52,888	49,756	45,198	36,379	61,089	35,084	44,638	34,081	36,930	37,377	36,979	35,113
Deferred revenue, net of current portion – related party
0	50,580	49,797	51,616	54,961	59,809	66,294	72,408	81,831	125,798	134,202	141,957	150,596	154,297	173,941	183,540	1,949	4,699	6,240	9,389	133	2,725	26,352	26,697	26,299	32,567	38,835	45,103	57,639
Operating lease liabilities, net of current portion
104,010	106,074	108,096	110,073	66,006	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Financing lease liabilities, net of current portion
571	673	0	0	0	17,608	17,826	17,815	18,002	18,155	15,080	16,003	16,911	17,773	18,649	17,719	16,740	17,360	17,433	15,631	11,007	3,724	423	145	186	220	-	288	343
Total liabilities
174,439	250,213	250,325	251,193	201,874	170,920	168,866	175,093	174,532	238,894	237,394	251,608	-	260,503	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other non-current liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	3	6	262	-	-
Restricted stock liability, net of current portion
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10	15
Commitments and contingent liabilities (Note 9)
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0
Stockholders’ equity:
Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at March 31, 2020 and December 31, 2019
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0
Preferred stock
0	0	0	0	0	0	0	0	0	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0
Common stock, $0.001 par value; 125,000,000 shares authorized; 68,789,925 and 68,401,105 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively
69	68	59	59	59	58	58	58	58	49	49	48	42	42	42	38	38	38	38	37	37	37	35	34	32	31	31	4	3
Additional paid-in capital
2,181,517	2,156,363	1,861,523	1,839,710	1,818,393	1,794,283	1,775,113	1,743,657	1,717,609	1,174,904	1,160,048	1,142,233	857,107	842,013	828,043	652,574	640,124	630,078	619,451	607,708	598,494	591,334	347,947	344,490	246,970	244,881	243,601	2,836	2,012
Accumulated other comprehensive income
74	202	464	490	-484	-2,171	-2,119	-2,398	-2,643	-1,389	-515	-650	-212	-313	29	297	89	-318	225	222	191	-57	51	12	33	14	25	-5	-2
Accumulated deficit
-1,556,361	-1,516,105	-1,413,755	-1,307,582	-1,197,711	-1,104,633	-1,012,839	-918,175	-849,430	-798,061	-709,776	-632,639	-549,557	-483,151	-426,665	-363,831	-307,878	-284,680	-244,057	-203,802	-171,905	-166,948	-140,284	-143,988	-125,692	-113,444	-101,062	-89,885	-74,037
Total stockholders’ equity
625,299	640,528	448,291	532,677	620,257	687,537	760,213	823,142	865,594	375,503	449,806	508,992	307,380	358,591	401,449	289,078	332,373	345,118	375,657	404,165	426,817	424,366	207,749	200,548	121,343	131,482	142,595	-87,050	-72,024
Total liabilities and stockholders’ equity
799,738	890,741	698,616	783,870	822,131	858,457	929,079	998,235	1,040,126	614,397	687,200	760,600	557,316	619,094	672,042	557,601	396,117	420,065	449,086	474,383	474,336	491,904	269,608	272,030	181,912	201,205	219,069	111,252	137,008